|
US10611837B2
(en)
|
2014-04-10 |
2020-04-07 |
Seattle Children's Hospital |
Transgene genetic tags and methods of use
|
|
DK3143134T3
(da)
|
2014-05-15 |
2021-01-04 |
Nat Univ Singapore |
Modificerede, naturlige dræberceller og anvendelser deraf
|
|
PL3560953T3
(pl)
|
2014-12-24 |
2024-05-13 |
Autolus Limited |
Komórka
|
|
GB201503742D0
(en)
*
|
2015-03-05 |
2015-04-22 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
AU2016306209B2
(en)
|
2015-08-07 |
2023-07-06 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Bispecific CAR T-cells for solid tumor targeting
|
|
US9681109B2
(en)
*
|
2015-08-20 |
2017-06-13 |
Qualcomm Incorporated |
Systems and methods for configurable demodulation
|
|
US11446398B2
(en)
|
2016-04-11 |
2022-09-20 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
BR112019019917A2
(pt)
*
|
2017-03-27 |
2020-04-22 |
Nat Univ Singapore |
receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais
|
|
CA3056591A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
CN107098981B
(zh)
*
|
2017-06-29 |
2020-05-01 |
青岛麦迪赛斯医疗技术有限公司 |
一种靶向cd19的嵌合抗原受体修饰的t淋巴细胞
|
|
US20210130775A1
(en)
*
|
2017-08-02 |
2021-05-06 |
Autolus Limited |
Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressed
|
|
KR102136063B1
(ko)
|
2017-12-06 |
2020-07-22 |
앱클론(주) |
악성 b 세포를 특이적으로 인지하는 항체 또는 그의 항원 결합 단편, 이를 포함하는 키메라 항체 수용체 및 이의 용도
|
|
CN107903326B
(zh)
*
|
2018-01-02 |
2020-06-30 |
广东省人民医院(广东省医学科学院) |
包含C3aR胞内结构域的嵌合抗原受体、慢病毒载体、表达细胞及药物
|
|
CN108047332B
(zh)
*
|
2018-01-15 |
2021-08-24 |
阿思科力(苏州)生物科技有限公司 |
以cd19为靶点的特异性抗体、car-nk细胞及其制备和应用
|
|
EP3749685A4
(en)
|
2018-02-09 |
2021-12-22 |
National University of Singapore |
ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY
|
|
CN111094358A
(zh)
*
|
2018-02-11 |
2020-05-01 |
江苏恒瑞医药股份有限公司 |
一种分离的嵌合抗原受体以及包含其的修饰t细胞及用途
|
|
JP7334985B2
(ja)
|
2018-04-02 |
2023-08-29 |
ナショナル ユニヴァーシティー オブ シンガポール |
免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和
|
|
CN116836297A
(zh)
*
|
2018-04-12 |
2023-10-03 |
上海赛比曼生物科技有限公司 |
靶向bcma的嵌合抗原受体及其制法和应用
|
|
WO2019220109A1
(en)
|
2018-05-15 |
2019-11-21 |
Autolus Limited |
Chimeric antigen receptor
|
|
GB201807870D0
(en)
|
2018-05-15 |
2018-06-27 |
Autolus Ltd |
A CD79-specific chimeric antigen receptor
|
|
CN108794642A
(zh)
*
|
2018-07-05 |
2018-11-13 |
宁波安诺柏德生物医药科技有限公司 |
一种嵌合抗原细胞受体及其应用
|
|
CN110819678A
(zh)
*
|
2018-08-07 |
2020-02-21 |
上海恒润达生生物科技有限公司 |
一种评估cart细胞有效性的方法
|
|
CN110850068B
(zh)
*
|
2018-08-21 |
2023-08-15 |
上海恒润达生生物科技股份有限公司 |
一种嵌合抗原受体亲和力检测方法
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
IL281428B2
(en)
*
|
2018-09-27 |
2024-10-01 |
Autolus Ltd |
Chimeric antigen receptor
|
|
GB201816522D0
(en)
|
2018-10-10 |
2018-11-28 |
Autolus Ltd |
Methods and reagents for analysing nucleic acids from single cells
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
EP3873540A4
(en)
|
2018-10-31 |
2022-07-27 |
Mayo Foundation for Medical Education and Research |
METHODS AND MATERIALS FOR THE TREATMENT OF CANCER
|
|
AU2019372673A1
(en)
|
2018-11-01 |
2021-05-27 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for T cell engineering
|
|
CN109468282B
(zh)
*
|
2018-11-22 |
2019-06-18 |
青岛协和华美医学诊断技术有限公司 |
一种靶向cd19的嵌合抗原受体t细胞的制备方法及应用
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
CN109734813B
(zh)
*
|
2019-01-28 |
2022-06-17 |
广东昭泰体内生物医药科技有限公司 |
一种嵌合抗原受体及其应用
|
|
US12241061B2
(en)
*
|
2019-02-04 |
2025-03-04 |
National University Corporation Ehime University |
CAR library and scFv manufacturing method
|
|
US12419913B2
(en)
|
2019-02-08 |
2025-09-23 |
Dna Twopointo, Inc. |
Modification of CAR-T cells
|
|
CA3130103A1
(en)
|
2019-02-13 |
2020-08-20 |
The Brigham And Women's Hospital, Inc. |
Anti-peripheral lymph node addressin antibodies and uses thereof
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
US20220145325A1
(en)
|
2019-03-08 |
2022-05-12 |
Autolus Limited |
Compositions and methods comprising engineered chimeric antigen receptor and modulator of car
|
|
GB201903237D0
(en)
|
2019-03-08 |
2019-04-24 |
Autolus Ltd |
Method
|
|
AU2020288829A1
(en)
*
|
2019-06-04 |
2021-12-02 |
Nkarta, Inc. |
Combinations of engineered natural killer cells and engineered T cells for immunotherapy
|
|
SG11202111943UA
(en)
|
2019-07-02 |
2021-11-29 |
Hutchinson Fred Cancer Res |
Recombinant ad35 vectors and related gene therapy improvements
|
|
AU2020315213A1
(en)
*
|
2019-07-17 |
2022-02-03 |
National University Of Singapore |
Functional binders synthesized and secreted by immune cells
|
|
EP4021485A1
(en)
|
2019-08-28 |
2022-07-06 |
King's College London |
B cell targeted parallel car (pcar) therapeutic agents
|
|
EP4065605A4
(en)
|
2019-11-26 |
2023-07-12 |
Ramot at Tel-Aviv University Ltd. |
Antibodies to carbohydrate antigens
|
|
AU2021207795A1
(en)
*
|
2020-01-13 |
2022-07-28 |
Nkarta, Inc. |
BCMA-directed cellular immunotherapy compositions and methods
|
|
CN115484978A
(zh)
|
2020-03-05 |
2022-12-16 |
尼奥克斯医疗有限公司 |
使用免疫细胞治疗癌症的方法和组合物
|
|
CN113402612A
(zh)
*
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
GB202005216D0
(en)
|
2020-04-08 |
2020-05-20 |
Autolus Ltd |
Cell
|
|
US20230348854A1
(en)
*
|
2020-05-08 |
2023-11-02 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Chimeric antigen receptors (cars) targeting natural killer cells
|
|
US20220031751A1
(en)
|
2020-08-03 |
2022-02-03 |
Kyverna Therapeutics, Inc. |
Methods of producing t regulatory cells, methods of transducing t cells, and uses of the same
|
|
US20230366893A1
(en)
*
|
2020-09-29 |
2023-11-16 |
Washington University |
Methods to determine risk of neurotoxicity
|
|
AR124414A1
(es)
|
2020-12-18 |
2023-03-22 |
Century Therapeutics Inc |
Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
|
|
EP4271817A2
(en)
|
2020-12-30 |
2023-11-08 |
Alaunos Therapeutics, Inc. |
Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof
|
|
WO2022165419A1
(en)
|
2021-02-01 |
2022-08-04 |
Kyverna Therapeutics, Inc. |
Methods for increasing t-cell function
|
|
US20240181055A1
(en)
*
|
2021-04-08 |
2024-06-06 |
Crage Medical Co., Limited |
Cellular immunotherapy use
|
|
CN117088975B
(zh)
*
|
2022-05-11 |
2024-06-25 |
东莞市朋志生物科技有限公司 |
抗白蛋白抗体、检测白蛋白的试剂和试剂盒
|
|
US20260097122A1
(en)
|
2022-05-11 |
2026-04-09 |
Autolus Limited |
Cd19/c22 car t-cell treatment of high risk or relapsed pediatric acute lymphoblastic leukemia
|
|
CN116253794B
(zh)
*
|
2022-08-19 |
2025-04-04 |
首都医科大学宣武医院 |
一种用于car-t细胞调控的抗体及其应用
|
|
KR20250131823A
(ko)
|
2023-03-31 |
2025-09-03 |
아벨제타 인크. |
Cd20 및 bcma를 표적화하는 이중특이적 키메라 항원 수용체
|
|
WO2024246526A1
(en)
|
2023-05-30 |
2024-12-05 |
Autolus Limited |
Cd19car t-cell treatment of relapsed/refractory b-cell acute lymphoblastic leukaemia
|
|
WO2025008642A1
(en)
|
2023-07-05 |
2025-01-09 |
Autolus Limited |
Method
|
|
CN119350497A
(zh)
*
|
2023-07-24 |
2025-01-24 |
星尘生物科技(上海)有限公司 |
人源化抗cd19单链可变区片段及其用途
|
|
GB202316184D0
(en)
|
2023-10-23 |
2023-12-06 |
Autolus Ltd |
Method
|
|
WO2025088308A1
(en)
|
2023-10-23 |
2025-05-01 |
Autolus Limited |
Products and methods for treating autoimmune diseases
|
|
EP4574838A1
(en)
|
2023-12-21 |
2025-06-25 |
Vilnius University |
Chimeric antigen receptor (car) with enhanced recruitment of signaling partners
|
|
GB202403564D0
(en)
|
2024-03-12 |
2024-04-24 |
Autolus Ltd |
Method
|
|
WO2025215360A1
(en)
|
2024-04-09 |
2025-10-16 |
Autolus Limited |
Method
|